References
- AzemarMDjahansouziSJägerE2003Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to Erb2/HER2Breast Can Res Treat8215564
- BalzarMWinterMJde BoerCJ1999The biology of the 17-1A antigen (Ep-CAM)J Mol Med7769971210606205
- BaselgaJTrigoJMBourhisJ2005Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neckJ Clin Oncol2355687716009950
- BlickSKScottLJ2007Cetuximab, a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancerDrugs67258560718034592
- BonnerJAHarariPMGiraltJ2006Radiotherapy plus cetuximab for squamous-cell carinoma of the head and neckN Engl J Med3545677816467544
- BossiPLocatiLLicitraL2007Biological agents in head and neck cancerExpert Rev Anticancer Ther716435018020930
- BrownJCizeauJBoscD2005A preclinical profile of VB4-845™, a recombinant immunotoxin for targeting head and neck cancer96th Annual Meeting of the American Association of Cancer Research
- ColeRDMcGuirtF1995Prognostic significance of skin involvement from mucosal tumors of the head and neckArch Otolaryngol Head Neck Surg121124687576469
- De BoerCJVan KriekenJHJMJanssen-van RhijnCM1999Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liverJ Pathology1882016
- DequanterDMbotiFBLothaireP2005Skin metastases from a head and neck carcinoma: a prognostic factor?B-Ent11131516255495
- Di PaoloCWilludaJKubetzkoS2003A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activityClin Cancer Res928374812855664
- FitzgeraldDPastanI1989Targeted toxin therapy for the treatment of cancerJ Natl Cancer Inst811455632550658
- GebbiaVGiulianiGValoriVM2007Cetuximab in squamous cell head and neck carcinomasAnn Oncol18supp6vi5vi717591832
- HaddadRAllenAWirthL2006Integrating novel agents into the curative treatment of head and neck cancerExpert Rev Anticancer Ther6157916445367
- HerbstRSArquetteMShinDM2005Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckJ Clin Oncol2355788716009949
- JerjesWUpileTBetzCS2007The application of photodynamic therapy in the head and neckDent Update344788618019486
- LaimerKFongDGastlG2008EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic featuresOral Oncol4472717418618
- Le TourneauCFaivreSSiuLL2007Molecular targeted therapy of head and neck cancer: review and clinical development challengesEur J Cancer4324576617904355
- LeónXHittRConstenlaM2005A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapyClin Oncol (R Coll Radiol)174182416149284
- LitvinovSVVeldersMPBakkerHA1994Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion moleculeJ Cell Biol125437468163559
- LitvinovSVBalzarMWinterMJ1997Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherinsJ Cell Biol1391337489382878
- MacDonaldGCGloverN2005Effective tumor targeting: strategies for the delivery of armed antibodiesCurr Opin Drug Discov Devel817783
- PastanIHassanRFitzgeraldDJ2006Immunotoxin therapy of cancerNat Rev Cancer65596516794638
- PastanIHassanRFitzgeraldDJ2007Immunotoxin treatment of cancerAnn Rev Med582213717059365
- PerentesisJPMillerSPBodleyJW1992Protein toxin inhibitors of protein synthesisBiofactors3173841599611
- PitmanKTJohnsonJT1999Skin metastases from head and neck squamous cell carcinoma: incidence and impactHead Neck215606510449673
- PosnerM2007Evolving strategies for combined-modality therapy for locally advanced head and neck cancerOncologist129677417766656
- PosnerMRWirthLJ2006Cetuximab and radiotherapy for head and neck cancerN Engl J Med3546343616467552
- RandRWKreitmanRJPatronasN2000Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high grade gliomaClin Can Res6215765
- RobertFEzekielMPSpencerSA2001Phase 1 study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerJ Clin Oncol1932344311432891
- SchmelzerFReidLM2008EpCAM expression in normal, non-pathological tissuesFront Biosci13309610017981779
- SiegallCBLiggittDChaceD1997Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugsClin Cancer Res3339459815690
- SittelCGossmannAJungehulsingM2001Superselective embolization as palliative treatment of recurrent hemorrhage in advanced carcinoma of the head and neckAnn Otol Rhinol Laryngol11011262811768702
- StoeckleinNHSiegmundAScheunemannP2006EpCAM expression in squamous cell carinoma of the esophagus: a potential therapeutic target and prognostic markerBMC Cancer61657316796747
- van HerpenCMHuijbensRLoomanM2003Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cellsClin Can Res9295056
- van HerpenCMLoomanMZonneveldM2004Intratumoral administration of recombinant interleukin 12 in head and neck squamous cell carcinoma patients elicits a T-helper 1 profile in the locoregional lymph nodesClin Can Res10262635
- von MehrenMAdamsGPWeinerLM2003Monoclonal antibody therapy in cancerAnn Rev Med543436912525678
- WentPTLugliAMeierS2004Frequent EpCam protein expression in human carcinomasHum Pathol351222814745734
- WinterMJNagtegaalIDvan KriekenJH2003The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathologyAm J Pathol16321394814633587
- YanamotoSKawasakiGYoshitomiI2007Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapyOral Oncol438697717207659
- YoskovitchAHierMPOkrainecA2001Skin metastases in squamous cell carcinoma of the head and neckOtolaryngol Head Neck Surg1242485211240984